US OptionsDetailed Quotes
QTRX241220P25000
- 0.00
- 0.000.00%
15min DelayClose Dec 10 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest25.00Strike Price0.00Turnover384.38%IV-112.22%PremiumDec 20, 2024Expiry Date13.22Intrinsic Value100Multiplier9DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8190Delta0.0365Gamma0.86Leverage Ratio-0.0982Theta-0.0048Rho-0.70Eff Leverage0.0050Vega
Quanterix Stock Discussion
ABOS PEPG TOPS AAPL DIS XPEV MNMD TSM QTRX
$Acumen Pharmaceuticals (ABOS.US)$ $PepGen (PEPG.US)$ $Top Ships (TOPS.US)$ $Apple (AAPL.US)$ $Disney (DIS.US)$ $XPeng (XPEV.US)$ $Mind Medicine (MNMD.US)$ $Taiwan Semiconductor (TSM.US)$ $Quanterix (QTRX.US)$
In reaction to earnings/guidance:
• $GoodRx (GDRX.US)$ +38.5%, $EDGIO (EGIO.US)$ +13.5%, $Lemonade (LMND.US)$ +10.7%, $Desktop Metal (DM.US)$ +8.5%, $ShockWave Medical (SWAV.US)$ +8.2%, $Pubmatic (PUBM.US)$ +8.1%, $Olaplex (OLPX.US)$ +7%, $Vivid Seats (SEAT.US)$ +6.4%, $Noble (NE.US)$ +6.3%, $Aspen Technology (AZPN.US)$ +5.4%, $AAON Inc (AAON.US)$ +5%, $Hudbay Minerals (HBM.US)$ +5%, $Vivint Smart Home (VVNT.US)$ +4.9%, $Vivint Smart Home (VVNT.US)$ +4...
• $MillerKnoll (MLKN.US)$ +12.4%, $BioNTech (BNTX.US)$ +7.4%, $Lululemon Athletica (LULU.US)$ +6.5% (also authorizes $1 bln stock repurchase program)
• $Adagio Therapeutics (ADGI.US)$ +52.47% (announces ADG20 (adintrevimab) is the first monoclonal antibody to meet primary endpoints with statistical significance across pre- and post-exposure prophylaxis and treatment for COVID-19 and plans to seek US emergency use authorization)
...
No comment yet